NSE: PARKHOSPS · BSE: 544645
PARK MEDI WORLD LIMITED
Operates a chain of multi-specialty hospitals across North India, with facilities spanning Delhi/NCR, Haryana, Punjab, Rajasthan, Uttar Pradesh and Uttarakhand. Served 8.7 lakh patients in FY26 — comprising 95,525 in-patient admissions and 7.78 lakh out-patient visits — with a network-wide occupancy of 64.1%. Revenue comes from hospital services across specialties; high-acuity work (cardiology, oncology, neurology, orthopaedics, urology, gastroenterology) contributed 56.9% of FY26 revenue, with specific procedures including 150+ kidney transplants, 4,700+ PTCA, 1,200+ cardio-vascular surgeries and 2,600+ robot-assisted joint replacements. Roughly 80% of payer mix comes from government insurance schemes (CGHS and others); a CGHS rate hike of 12-15% is expected to lift FY27 revenue by 7-7.5%. Costs are dominated by other operating expenses (36.7% of revenue) and employee costs (19.3%); materials run at 17.6%. The group is expanding toward 5,460 beds by March 2028 via greenfield projects (Panchkula, Kanpur, Gorakhpur, Rohtak) and acquisitions, including The Medicity Hospital in Rudrapur (330 beds, INR 177 crore deal). AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. In-patient high-acuity specialties (57%), Other in-patient and out-patient hospital services, Government insurance scheme patients, Private insurance and walk-in patients. Asset-heavy, capacity-expanding hospital chain with high government-payor exposure and a large greenfield-plus-acquisition build-out plan.
Exhibit 1: Financial summary, FY26–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY26 |
|---|---|
| Revenue | 1,679 |
| EBITDA (ex other income) | 444 |
| margin % | 26.5 |
| Owners' profit | 258 |
| EPS, as reported (₹) | 6.87 |
| ROE % · ROCE % | 13.0 · 18.1 |
| Debt / equity (x) | 0.11 |
| Cash from operations | 329 |
| Capex | (120) |
Exhibit 2: Quarterly performance, last 3 quarters
| ₹ crore | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|
| Revenue | 410 | 460 | 476 |
| Profit before tax | 78 | 103 | 105 |
| Net profit | 53 | 77 | 89 |
| EPS (₹) | 1.35 | 1.78 | 2.05 |
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| APOLLO HOSPITALS ENTER. L | 1,12,042 | 53.6 | 11.23 | 29.6 | 20.1 | 16.6 | 19.0 | 16.2 |
| MAX HEALTHCARE INS LTD | 82,239 | 56.4 | 7.65 | 36.1 | 13.4 | 11.1 | 27.3 | 27.0 |
| FORTIS HEALTHCARE LTD | 55,603 | 53.1 | 5.47 | 27.5 | 10.5 | 9.7 | 17.8 | 22.0 |
| NARAYANA HRUDAYALAYA LTD. | 35,048 | 42.7 | 7.72 | 23.5 | 17.8 | 9.2 | 25.0 | 18.8 |
| ASTER DM QUALITY CARE LTD | 34,204 | 106.8 | 7.08 | 34.9 | 8.8 | 8.5 | (11.6) | 14.3 |
| GLOBAL HEALTH LIMITED | 33,865 | 60.9 | 8.50 | 34.4 | 13.9 | 13.5 | — | 23.7 |
| KRISHNA INST OF MED SCI L | 29,211 | 136.4 | 11.42 | 39.7 | 9.5 | 5.1 | 24.0 | 20.3 |
| DR AGARWALS HEALTH CARE L | 15,073 | 101.4 | 7.11 | 24.6 | 7.9 | 7.1 | — | 28.8 |
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 44.0 | 42.2 | 18 of 30 | 41% |
| P/B | 4.7 | 5.4 | 9 of 24 | 65% |
| ROCE | 15.5 | 10.9 | 4 of 30 | 90% |
| ROE | 13.0 | 11.8 | 10 of 24 | 61% |
| Debt / Equity | 0.1 | 0.2 | 8 of 24 | 70% |
| EBITDA margin | 28.1 | 22.0 | 6 of 24 | 78% |
| Market cap | 9854 | 2481 | 10 of 30 | 69% |
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 23 Oct 2026 · Income tax verification at company and subsidiary premises | regulatory legal | high | — | — |
| 14 Oct 2026 · Income Tax verification conducted at company and subsidiary premises | regulatory legal | high | — | — |
| 8 Oct 2026 · Routine SEBI Regulation 74(5) certificate filing for Jul-Sep 2026 quarter | compliance | minimal | — | — |
| 28 Sept 2026 · Trading window closed from Oct 1 until 48 hours after Q2 results announcement | compliance | minimal | — | — |
| 22 Sept 2026 · Park Medi World 15th AGM results: all 6 resolutions passed including ESOP changes | compliance | low | — | — |
| 22 Sept 2026 · Summary of 15th AGM proceedings held on September 22, 2026 | board shareholder meetings | medium | — | — |
| 22 Sept 2026 · Park Group of Hospitals Wins Three Awards at Healthcare Pioneers of Delhi 2026 | business updates | medium | — | — |
| 16 Sept 2026 · Park Medi World cancels participation in Anand Rathi G-200 Summit | investor communications | low | — | — |
| 16 Sept 2026 · Park Medi World unit signs 28-year O&M deal for 300-bed Kanpur hospital | strategic transactions | high | — | — |
| 8 Sept 2026 · Park Medi World incorporates wholly owned Prayagraj hospital subsidiary | strategic transactions | medium | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.